Balang, Samera .
HRN: 24-53-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
CLINDAMYCIN 300MG (CAP)
05/18/2026
05/24/2026
PO
300
Q12H
DM Foot
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines